Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidder
01:49pm, Sunday, 11'th Dec 2022
French health group Sanofi said on Sunday that it no longer intends to make an offer for biotech company Horizon Therapeutics Plc HZNP.O, leaving Amgen Inc as the only remaining bidder.
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
09:15am, Sunday, 11'th Dec 2022
Amgen recently shared positive clinical trial results for a heart disease drug candidate.
Amgen: A Solid Dividend Growth Stock For Your Watchlist
05:55am, Sunday, 11'th Dec 2022 Seeking Alpha
Amgen's sales have increased by 52% over the last decade and it equates to ~4% annually. Learn more about AMGN stock and see why it is a Hold.
Amgen: A Solid Dividend Growth Stock For Your Watchlist
12:55am, Sunday, 11'th Dec 2022
Amgen has shown a long track record of great execution. Investors in Amgen have enjoyed a decade of impressive dividend increases.
This Monster Dividend Stock Isn't Done Growing
02:00pm, Thursday, 08'th Dec 2022 The Motley Fool
Is another deal on the way for Johnson & Johnson?
Mirati (MRTX) Down After 1st-Line Lung Cancer Data on Adagrasib
03:57pm, Wednesday, 07'th Dec 2022 Zacks Investment Research
Mirati Therapeutics' (MRTX) preliminary data from the first-line NSCLC study showed that adagrasib plus Merck's Keytruda achieved an objective response rate of 49%.
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
10:17am, Tuesday, 06'th Dec 2022
Mirati said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed on questions about its market opportunity. The post Mirati Therapeutics Crashes As The Cancer Rivalry W
Is AbbVie Stock a Buy Now?
10:10am, Tuesday, 06'th Dec 2022 The Motley Fool
The pharmaceutical company prepared well as Humira approaches its patent cliff next year.
Amgen Inc. (AMGN) World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference (Transcript)
12:55pm, Monday, 05'th Dec 2022
Amgen Inc. (NASDAQ:AMGN ) World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference Call December 5, 2022 8:00 AM ET Company Participants David Reese - Executive Vice Presid
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
09:43am, Monday, 05'th Dec 2022
Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday. The post Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sa
7 Christmas Stocks to Buy for Happy Holidays
06:30am, Monday, 05'th Dec 2022
It makes sense if you haven't been thinking much about Christmas stocks. You really can't be blamed for not being in the Christmas spirit this year.
Dow Stocks To Trade In December
12:00pm, Sunday, 04'th Dec 2022
December is likely to bring higher prices. Here are long and short recommendations.
Dividend Champion, Contender, And Challenger Highlights: Week Of December 4
05:29am, Sunday, 04'th Dec 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates.
FTX Collapse: Lessons for Investors
05:55pm, Saturday, 03'rd Dec 2022 The Motley Fool
Plus a look at "the dumbest index."
Is Amgen Stock a Buy for Income Investors?
11:40am, Friday, 02'nd Dec 2022 The Motley Fool
Amgen's dividend yield is materially higher than the S&P 500 index's yield.
